Voriconazole and posaconazole therapeutic drug monitoring: a retrospective study
Abstract Background Therapeutic drug monitoring (TDM) aims to minimize the clinical impact of posaconazole and voriconazole pharmacokinetic variability. However, its benefits on clinical outcomes are still being defined. Additionally, TDM data are limited for posaconazole IV and delayed-release tabl...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-09-01
|
Series: | Annals of Clinical Microbiology and Antimicrobials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12941-017-0235-8 |